Ministry of Public Health aims to allocate COVID-19

Toutes vos questions sur le Covid-19 et ses conséquences
Répondre
limited
Messages : 29
Enregistré le : ven. août 28, 2020 6:15 am
Mon U.F.R : AMIENS

mar. oct. 13, 2020 4:42 am

Ministry of Public Health aims to allocate COVID-19 vaccine For Thai people within the first half of the year '64



Image


Ministry of Public Health (Ministry of Public Health), along with Siam BioScience, SCG and AstraZeneca. Leading English-Swedish manufacturer of biofilms Jointly sign a Letter of Intent for the production and allocation of a research vaccine against COVID-19 AZD1222 developed by the University of Oxford.
With the said letter of intent stating that เกมยิงปลา All parties agreed to work together. To enhance the production capacity of Siam Bioscience Company Ready to support mass production of vaccines To provide Thailand and Southeast Asian countries with equal and timely access to vaccines. The research vaccine will be allocated as a non-profit during the COVID-19 epidemic. At the same time, technology will be transferred and collaborated with Siam Bioscience. In the production process installation


The partnership is driven by the Ministry of Public Health to build confidence in the production in Thailand. The ministry will receive the AZD1222 research vaccine after being inspected and certified to the highest safety standards. The goal is to begin allocating vaccines for Thai citizens within the first half of 2021.


Anutin Charnvirakul, Deputy Prime Minister and Minister of Public Health, said he was delighted that AstraZeneca chose Thailand as one of the world's production bases through the company. Siam Bioscience The signing of the letter of intent represents another step forward in the domestic supply of research vaccines. Which will increase the confidence of the people And the recovery of the Thai economy The government also supports the distribution of research vaccines to neighboring countries so that the entire region will return to normal quickly.


Gen. Satitpong Sukwimol, Chairman of the Board of Siam BioScience Co., Ltd., said that the Company's production center. There are high-tech machines for the production of cancer drugs and autoimmune diseases. The machine could be applied to produce research vaccine AZD1222 to prevent COVID-19. From the university of Oxford And AstraZeneca After technology transfer from AstraZeneca and FDA procedures, the first vaccine is expected to be ready in the middle of next year. This will enable Thailand to successfully produce the vaccine as the first country in Southeast Asia. The company will make every effort to enable Thai people and people of Southeast Asia to use the vaccine as quickly as possible.


Mr. Roongrote Rangsiyopash President The Siam Cement Plc. (SCC) or SCG said this partnership will help Thailand speed up the use of the COVID-19 vaccine, as well as neighboring countries. This will help to promote the economy and society of Thailand and ASEAN to return to normal again. We would like to thank AstraZeneca's vaccine team for always cooperating with this cooperation. Has contributed to research and develop vaccines in the country of 100 million baht.
Répondre